ReviewDiscover oncology2026

Role of CTLA-4 blockade and dacarbazine therapy following anti-PD-1 resistance in melanoma.

Vincas Urbonas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.